ADVENT CAPITAL MANAGEMENT /DE/ - HAEMONETICS CORP MASS ownership

HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6. A total of 52 filers reported holding HAEMONETICS CORP MASS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ADVENT CAPITAL MANAGEMENT /DE/ ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$34,816,240
-23.7%
39,904,000
-25.2%
0.81%
-8.3%
Q2 2023$45,660,417
-10.9%
53,348,000
-11.2%
0.88%
-8.9%
Q1 2023$51,254,215
+2.7%
60,053,000
+0.0%
0.97%
+11.9%
Q4 2022$49,913,746
+2.7%
60,043,000
-1.2%
0.87%
-1.7%
Q3 2022$48,609,000
+10.7%
60,765,000
+9.0%
0.88%
+13.4%
Q2 2022$43,916,000
+6.5%
55,765,000
+13.9%
0.78%
+17.7%
Q1 2022$41,243,00048,979,0000.66%
Other shareholders
HAEMONETICS CORP MASS shareholders Q3 2023
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,705,0001.15%
Context Capital Management, LLC 14,558$12,6601.02%
Quaero Capital S.A. 1,200,000$1,042,4400.99%
READYSTATE ASSET MANAGEMENT LP 22,200,000$19,369,5000.97%
DeepCurrents Investment Group LLC 24,371,000$21,212,5170.92%
ADVENT CAPITAL MANAGEMENT /DE/ 39,904,000$34,816,2400.81%
SSI INVESTMENT MANAGEMENT LLC 10,872,000$9,431,4620.77%
Empyrean Capital Partners, LP 13,500,000$11,696,9590.72%
MACKAY SHIELDS LLC 29,294,000$25,825,1100.71%
Aequim Alternative Investments LP 20,500,000$17,886,2500.68%
View complete list of HAEMONETICS CORP MASS shareholders